NHS to make new drug Denosumab available to bone cancer patients
Friday 17 August 2012
Thousands of cancer patients whose disease has spread to the bone are to benefit from a new drug which is to be made available on the NHS.
Denosumab (Xgeva) helps prevent bone complications in people whose cancer has spread from its original site.
These complications include bone fractures, spinal compression - when the spinal cord is compressed by the bone - and bone complications requiring radiotherapy or surgery.
Symptoms include pain as well as weakening and eventual destruction of the bone.
The National Institute for Health and Clinical Excellence (Nice) has published its final draft guidance which recommends the drug for certain groups of cancer patients whose disease has spread, most commonly to the spine, pelvis, hip, upper leg bones and skull.
The conditions include bone tumours from breast cancer and other solid tumours not relating to the breast or prostate, such as lung or kidney cancer.
Professor Carole Longson, director of the Centre for Health Technology Evaluation at Nice, said: "Bone metastasis can severely affect a person's quality of life, stopping them from doing things so many of us take for granted.
"We are therefore pleased that our draft guidance recommends denosumab for those patients who are most likely to benefit from the treatment."
Tara Beaumont, clinical nurse specialist for secondary breast cancer patients at Breast Cancer Care, said: "The Nice approval of denosumab marks a positive milestone for secondary breast cancer patient choice and quality of life, which we warmly welcome.
"People whose breast cancer has spread to their bones can experience a reduction in quality of life, and currently have limited treatment options, so making denosumab available through the NHS means that there is another option for people for whom bisphosphonates are not appropriate.
"As denosumab can be given as an injection under the skin rather than intravenously (into the vein), it also offers patients a different route of administration, which may be more convenient.
"We hope that this announcement paves the way for similar positive developments in secondary breast cancer treatment and raises awareness of the importance of quality of life and symptom management for those living with incurable cancer."
If no appeals are lodged against the guidance, it will be published later this year and patients will be able to get the treatment on the NHS.
arts + entsThere were towering ideas, some scintillating performances and revelatory grooves... our writers pick out their personal highlights
elephant appealThe first 23 lots in our charity auction have now gone. But there are 22 more still up for grabs
elephant appealPrince William signs up for our charity appeal
peoplePrepare to be entranced by worms as the molecular biologist gets ready to give the Royal Institution science lectures
elephant appealSo says man jailed for cutting off dead elephant's tusks
booksWe examine the best titles for teens
voicesPeople moan that Christmas is too commercial, the spirit lost. But it is a time to over-indulge, and always has been, says DJ Taylor
scienceResearchers teach border collie to understand sentences using more than 1,000 words
booksA Christmas story in six parts
travelWill high-value tourism help the workshops of this Renaissance city?
food + drinkA trifle without custard? Surely not! Nonsense – and here’s three to finish your festive meal that prove it
Geoffrey Macnab does not like the comedian's big screen debut
Life & Style blogs
Drunken assaults, drug abuse, spiked drinks – and a young couple in a pine tree: Not a very merry Christmas for the paramedics
The 10 Best Scotch Whiskies
America's 'virgin births'? One in 200 mothers 'became pregnant without having sex'
GTA 5: Rockstar bans gamers stealing in-game money worth millions
Winter Solstice 2013: Shortest day of the year marked with 'knitted' Google Doodle
- 1 Top PR exec Justine Sacco under fire for sending racist tweet before flying to Africa
- 2 French pub fined €9,000 after customers returned empties to bar - because it's 'undeclared labour'
- 3 Sun will 'flip upside down' within weeks, says Nasa
- 4 The publisher who played with fire: the battle for control of Larsson's £30m legacy
- 5 Police seize possessions of rough sleepers in crackdown on homelessness
- < Previous
- Next >
£40000 - £65000 per annum + Benefits : Harrington Starr: C#.NET Developer (WPF...
£45000 - £65000 per annum + London: Harrington Starr: Senior Automation QA Eng...
Negotiable: Capita Education Resourcing Permanent Team: Year 6 Teacher - Gilli...
Negotiable: Capita Education Resourcing Permanent Team: Teacher of English - S...